Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 733-738

  Mouton, Johan W ^a   Vinks, Alexander A T M M ^b   Punt, Nieko C ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Clinical Pharmacy   (Netherlands)

^c Data Sciences   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030985564     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.733     Document Type: Article

References (15)

1. Blaser, J. 1985. In vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 15(Suppl. A):125-130.
2. Bouvier d'Yvoire M. J. Y., and P. H. Maire. 1996. Dosage regimens of antibacterial. Implications of a pharmacokinetic/pharmacodynamic model. Clin. Drug Investig. 11:229-239.
3. Eandi, M., and G. P. L. Cecina. 1985. Pharmacokinetic factors in antibiotic effect: a dynamic system approach to the healing process, p. 3-30. In A. Genazzani (ed.), Pharmacokinetics and antibiotic efficacy. Proceedings of an international workshop. Masson Italia Editori, Milan, Italy.
4. Levy, G. 1994. Mechanism-based pharmacodynamic modeling. Clin. Pharmacol. Ther. 56:256-358.
5. Maire, P., X. Barbaut, A. Schumitzy, and R. W. Jelliffe, 1994. Clinical computations of bacterial growth and kill dynamics - implications for therapy, abstr. A83, p. 146. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Mattie, H. 1978. A mathematical description of short-term effects of betalactam antibiotics on bacterial growth in vitro. Curr. Microbiol. 1:105-109.
7. Mattie, H., A. M. van Dokkum, L. Brus-Weijer, A. M. Krul, and E. van Strijen. 1990. Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. J. Infect. Dis. 162:717-722.
8. Mattie, H., B. A. Razab Sekh, M. L. van Ogtrop, and E. van Strijen. 1992. Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo. Antimicrob. Agents Chemother. 36: 2439-2443.
9. Mouton, J. W., and J. G. den Hollander. 1994. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 38:931-936.
10. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. Nolting, A., and H. Derendorf. 1995. Pharmacokinetic/pharmacodynamic modeling of antibiotics, p. 363-388. In H. Derendorf and G. Hochhaus (ed.), Handbook of Pharmacokinetic/pharmacodynamic correlation. CRC Press, Boca Raton, Fla.
12. Vogelman, B., and W. A. Craig. 1986. Kinetics of antibacterial activity. J. Pediatr. 108:835-840.
13. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175.
14. Zhi, J., C. H. Nightingale, and R. Quintilliani. 1986. A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J. Pharm. Sci. 75:1063-1067.
15. Zhi, J., C. H. Nightingale, and R. Quintilliani. 1988. Microbial pharmacodynamics of piperacillin in neutropenic mice of systemic infection due to Pseudomonas aeruginosa. J. Pharmacokinet. Biopharm. 16:355-358.